next wave of growth in the Americas 2018 Corpus Christi (1/3 ownership in JV) Significant step forward in IVL value- creating strategy underpinning strong growth momentum Creates new and exciting
-2023 PET: 367 kta PTA: 433 kta Double digit ROCE 700-800 (till Dec’19: 381) Recycling projects PET recycling 2020-2023 ~600kta ROCE 12-14% 700-800 9 IVL Strategic Priorities Going Forward IVL remains
Quarter 2020 MD&A 8 IVL Strategic Priorities Going Forward IVL remains focused on its financial objective for 2023 - to achieve double-digit ROCE in each of its core businesses; top decile total shareholder
Working capital and inventory management IVL Strategic Priorities Going Forward IVL remains focused on its financial objective for 2023 - to achieve double-digit ROCE in each of its core businesses; top
in Asia. Going forward, structural changes taking place in Asia should benefit the industry as a whole. Lack of new announcements in capacity expansions and continued growth in demand is a positive
express written approval of the Company. Some statements made in this presentation are forward-looking statements, which are subject to various risks and uncertainties. These include statements with respect
% MB % MB % 1. Wellness and Anti-aging 128.58 40.58% 162.70 43.82% 34.12 26.54% 2. Aesthetic Innovation 96.00 30.30% 67.17 18.09% (28.83) (30.03%) 3. Companion Animal Health 80.78 25.50% 132.19 35.60
of Baht 25 million and animal and plants of Baht 20.14 million from death of animal as significant. Liabilities As at June 30, 2018, the Company had total liabilities of Baht 751.66 million decreased
Innovation 2.94 3.03 24.11 28.39 (21.17) (87.80%) 3. Companion Animal Healthcare 43.06 44.33 25.70 30.26 17.35 67.51% 4. Livestock 3.36 3.45 3.25 3.82 0.11 3.36% Total Sales Revenue 97.13 100.00 84.93 100.00
Report Better performance of Thai Economy in Q1/FY2019 pushed forward the market’s growth in every aspect, as well as growth of Thai GDP that led to; 1. Increase in Company’s revenue around 73.39 million